Stem cell super soldiers take on autoimmune diseases
NCT ID NCT07301164
First seen Jan 04, 2026 · Last updated May 15, 2026 · Updated 21 times
Summary
This early-phase study tests a new treatment called BCT301 for people with severe autoimmune diseases like lupus and scleroderma that haven't responded to standard therapies. BCT301 uses immune cells made from stem cells to target and attack faulty immune cells. The main goal is to check safety and find the right dose, with a small group of 10 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS (SSC) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.